Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-16-000945

← back to feed
Filed
Nov 15, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 14, 2016 21.37M sh
Operating Cash Flow Q3 2016 · Sep 30, 2016 −$149.39K
Operating Cash Flow Q3 2016 · Sep 30, 2015 −$333.03K
Cash And Equivalents Q3 2016 · Sep 30, 2016 $9.95K
Cash And Equivalents Q3 2016 · Dec 31, 2015 $19.84K
Cash And Equivalents Q3 2016 · Sep 30, 2015 $52.21K
Cash And Equivalents Q3 2016 · Dec 31, 2014 $322.93K
Stockholders Equity Q3 2016 · Sep 30, 2016 −$430.61K
Stockholders Equity Q3 2016 · Dec 31, 2015 −$441.5K
Current Liabilities Q3 2016 · Sep 30, 2016 $443.09K
Current Liabilities Q3 2016 · Dec 31, 2015 $468.58K
Total Liabilities Q3 2016 · Sep 30, 2016 $464.09K
Total Liabilities Q3 2016 · Dec 31, 2015 $494.58K
Current Assets Q3 2016 · Sep 30, 2016 $9.95K
Current Assets Q3 2016 · Dec 31, 2015 $23.46K
Total Assets Q3 2016 · Sep 30, 2016 $33.48K
Total Assets Q3 2016 · Dec 31, 2015 $53.08K
Sga Expense Q3 2016 · Sep 30, 2016 $178.9K
Sga Expense Q3 2016 · Sep 30, 2016 $478.54K
Sga Expense Q3 2016 · Sep 30, 2015 $180.34K
Sga Expense Q3 2016 · Sep 30, 2015 $580.97K
Rd Expense Q3 2016 · Sep 30, 2016 $31.45K
Rd Expense Q3 2016 · Sep 30, 2016 $100.93K
Rd Expense Q3 2016 · Sep 30, 2015 $23.48K
Rd Expense Q3 2016 · Sep 30, 2015 $100.84K
Net Income Q3 2016 · Sep 30, 2016 −$212.43K
Net Income Q3 2016 · Sep 30, 2016 −$874.59K
Net Income Q3 2016 · Sep 30, 2015 −$207.28K
Net Income Q3 2016 · Sep 30, 2015 −$688.31K
Operating Income Q3 2016 · Sep 30, 2016 −$211.75K
Operating Income Q3 2016 · Sep 30, 2016 −$584.97K
Operating Income Q3 2016 · Sep 30, 2015 −$206.78K
Operating Income Q3 2016 · Sep 30, 2015 −$686.75K
Revenue Q3 2016 · Sep 30, 2016 $595
Revenue Q3 2016 · Sep 30, 2016 $595
Capex Q3 2016 · Sep 30, 2015 $37.69K